期刊文献+

肥胖的药物、手术和介入治疗 被引量:4

Pharmacotherapy, surgery and intervention treatment in obesity management
原文传递
导出
摘要 全球肥胖人数迅猛增加,肥胖相关并发症也逐渐出现。肥胖治疗主要目的除了减轻体质量,还包括减少肥胖相关并发症的出现和避免体质量的反弹。近年来,奥利司他等多种可长期治疗肥胖的药物陆续进入临床,减重手术和胃左动脉栓塞术也开始兴起。本文系统综述肥胖的药物治疗、手术和介入治疗进展及其临床评价。 Obesity has rapidly increased and the obesity-related comorbidities have been emerged as well. The treatment for obesity is not only aimed to lose weight, but also to reduce the occurrence of obesity-related comorbidities and to avoid regaining weight. Recently, the orlistat and other obesity drugs have been used in clinic successively. However, the bariatric surgery and left gastric artery embolization have been expanded over recent years alternatively. This review describes the pharmacotherapy, surgery and interventional treatment for the management of obesity.
作者 胡珂 陆志强 HU Ke, LU Zhi-qiang(Department of Endocrinology, Zhongshan Hospital, Fudan University, Shanghai 200032, Chin)
出处 《世界临床药物》 CAS 2018年第3期199-203,共5页 World Clinical Drug
关键词 肥胖 药物治疗 减重手术 介入治疗 obesity pharmacotherapy bariatric surgery interventional treatment
  • 相关文献

参考文献2

二级参考文献58

  • 1寇玉彬,郑成竹,印慨,柯重伟,胡旭光,陈丹磊.腹腔镜可调控性胃捆扎带减肥术治疗病态肥胖术后并发症的诊治[J].中华外科杂志,2006,44(21):1473-1476. 被引量:6
  • 2郑成竹,李际辉.中国肥胖病外科治疗指南(2007)[J].中国实用外科杂志,2007,27(10):759-762. 被引量:169
  • 3陈孝平,汪建平.外科学[M].8版.北京:人民卫生出版社,2013:408-409.
  • 4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China [J]. N Engl J Med, 2010, 362 (12) : 1090-1101.
  • 5Perna M, Romagnuolo J, Morgan K, et al. Preoperative hemo- globin Alc and postoperative glucose control in outcomes after gastric bypass for obesity[J]. Surg Obes Relat Dis, 2012,8(6) : 685-690.
  • 6Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in chinese adults[J]. JAMA,2013,310(9) :948-959.
  • 7Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients withdiabetes [J]. N Engl J Meal,2012,366(17) : 1567-1576.
  • 8Yimcharoen P, Heneghan HM, Singh M. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass [ J ]. Surg Endosc, 2011,25 (10) : 3345-3352.
  • 9Cui Y, Elahi D, Andersen DK. Advances in the etiology andmanagement of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass [J]. J Gastrointest Surg, 2011, 15 (10) : 1879-1888.
  • 10Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery ver- sus intensive medical therapy for diabetes--3-year outcomes [J]. N Engl J Med,2014,370(21 ) : 2002-2013.

共引文献311

同被引文献41

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部